ImmunoScape Pte
Latest round
- Series B
Last raised
- Dec 2022
Total raised
- $33M
Investors
- 5
About ImmunoScape Pte
Founded in 2017 and headquartered in Singapore, ImmunoScape Pte Ltd specializes in pre-clinical biotechnology, concentrating on TCR-T cell therapies for oncology. The founding team includes Choon Peng Ng, who serves as the CEO, and Evan Newell.ImmunoScape specializes in developing next-generation TCR-T cell therapies designed to effectively target solid tumors. The therapies aim to enhance the body's immune response against cancer cells, providing innovative treatment approaches for significant unmet medical needs.42 mn, the company plans to use this capital to focus on advancing product development. Additionally, ImmunoScape is strategizing on expanding into new geographic markets, continuing to leverage growth opportunities in the United States, Europe, and Asia.
Who invested in ImmunoScape Pte
5 investors across 3 rounds
See all investors in ImmunoScape Pte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ImmunoScape Pte
Who invested in ImmunoScape Pte?
ImmunoScape Pte has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmunoScape Pte raised?
ImmunoScape Pte has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ImmunoScape Pte last raise money?
ImmunoScape Pte's most recent round on record is a Series B, in Dec 2022.
What does ImmunoScape Pte do?
Founded in 2017 and headquartered in Singapore, ImmunoScape Pte Ltd specializes in pre-clinical biotechnology, concentrating on TCR-T cell therapies for oncology.
Where is ImmunoScape Pte headquartered?
ImmunoScape Pte is headquartered in Singapore, Singapore.
Which VCs invest in companies like ImmunoScape Pte?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ImmunoScape Pte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ImmunoScape Pte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.